News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Agency Starts In-Depth Review Of Ariad Pharmaceuticals, Inc. (ARIA) Leukemia Drug


12/6/2013 7:14:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

European regulators have started an in-depth review of the benefits and risks of Ariad Pharmaceuticals Inc's leukaemia medicine Iclusig. The European Medicines Agency (EMA) said on Friday the probe would look particularly at the risk of blood clots or blockages in the arteries or veins associated with the medicine.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   
Leukemia

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES